Stay updated on Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.

Latest updates to the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The displayed site revision changes from v3.7.0 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe study page for NCT03490344 now presents a 403 Forbidden error, making the page inaccessible; the 403 page replaces the usual study details and navigation.SummaryDifference18%

- Check46 days agoChange DetectedRevision indicator on the page now shows Revision: v3.7.0, replacing v3.6.6, signaling a platform update rather than changes to study content.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.6.6 was added, indicating a new page version. Related topics entries for Multiple Myeloma and MedlinePlus Genetics, the 'related topics:' label, and the older 'Revision: v3.6.5' entry were removed.SummaryDifference0.2%

- Check67 days agoChange DetectedThe page now includes the term 'Multiple myeloma' and adds a related topics entry for MedlinePlus Genetics. This provides clearer disease context and directs users to reputable background resources.SummaryDifference0.2%

- Check74 days agoChange DetectedThe page no longer displays the primary disease term 'Multiple Myeloma', the 'related topics' section header, or the MedlinePlus Genetics link. This changes how the study is categorized and what related resources are presented.SummaryDifference0.2%

Stay in the know with updates to Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.